4-chloro-5-hydroxy-2-(oxan-2-yl)pyridazin-3-one结构式
|
常用名 | 4-chloro-5-hydroxy-2-(oxan-2-yl)pyridazin-3-one | 英文名 | 4-chloro-5-hydroxy-2-(oxan-2-yl)pyridazin-3-one |
---|---|---|---|---|
CAS号 | 645405-18-1 | 分子量 | 230.64800 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C9H11ClN2O3 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | 4-chloro-5-hydroxy-2-(oxan-2-yl)pyridazin-3-one |
---|---|
英文别名 | 更多 |
分子式 | C9H11ClN2O3 |
---|---|
分子量 | 230.64800 |
精确质量 | 230.04600 |
PSA | 64.35000 |
LogP | 1.30140 |
~90% 4-chloro-5-hydr... 645405-18-1 |
文献:NEUROCRINE BIOSCIENCES, INC. Patent: WO2005/103039 A1, 2005 ; Location in patent: Page/Page column 36 ; WO 2005/103039 A1 |
~87% 4-chloro-5-hydr... 645405-18-1 |
文献:Ma, Chen; Cho, Su-Dong; Falck; Shin, Dong-Soo Heterocycles, 2004 , vol. 63, # 1 p. 75 - 85 |
~% 4-chloro-5-hydr... 645405-18-1 |
文献:Dyck, Brian; Markison, Stacy; Zhao, Liren; Tamiya, Junko; Grey, Jonathan; Rowbottom, Martin W.; Zhang, Mingzhu; Vickers, Troy; Sorensen, Katie; Norton, Christi; Wen, Jenny; Heise, Christopher E.; Saunders, John; Conlon, Paul; Madan, Ajay; Schwarz, David; Goodfellow, Val S. Journal of Medicinal Chemistry, 2006 , vol. 49, # 13 p. 3753 - 3756 |
3(2H)-Pyridazinone,4-chloro-5-hydroxy-2-(tetrahydro-2H-pyran-2-yl) |